What Is A "Black Box Warning" For MS Drugs?
NOVANTRONE® therapy in patients with MS and in patients with cancer increases the risk of developing secondary acute myeloid leukemia. Secondary The occurrence of refractory secondary leukemia is more common when anthracyclines What is a "Black Box Warning" for MS Drugs ... Read Article
Acute Myeloid Leukemia With T(9;11)(p21-22;q23)
Relapsed/refractory AML, acute myeloid leukemia; FLT3 TK, codon 835/836 kinase domain mutation; ITD, internal tandem duplication; MPO, myeloperoxidase; NS, not statistically significant; NSE, nonspecific esterase; OS, overall survival. ... Access Doc
Positive Data To FDA Soon - Venetoclax For Hard-to-treat CLL
Evaluates the efficacy and safety of venetoclax in patients with relapsed or refractory CLL with the 17p deletion. including indolent non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, acute myeloid leukemia and multiple myeloma. Background and Sources on BCL-2 and CLL. ... Read Article
2012 Update On Myeloid Neoplasms: Myelodysplastic Syndrome ...
2012 Update on Myeloid Neoplasms: Myelodysplastic Syndrome and Acute Myeloid Leukemia Ronald L. Weiss, M.D. University of Utah ARUP Laboratories ... Access Doc
Relapsed AML: Dr Steve Kornblau - YouTube
Dr Steve Kornblau, Professor, MD Anderson Cancer Center, gave presentation on the treatment advances in relapsed/refractory AML at BTG2013 Hong Kong. ... View Video
A Icle Acute Myeloid Leukemia Gemtuzumab Ozogamicin In ...
Acute myeloid leukemia (AML) in older adults remains a difficult-to-treat disease, with most patients either relapsing azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study ... View Document
A Phase II Study Of Lenalidomide Alone In Relapsed/Refractory ...
A Phase II Study of Lenalidomide Alone in Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes With Chromosome 5 Abnormalities ... Fetch This Document
Blinatumomab Shown To Be Beneficial In Relapsed/refractory B ...
Visit http://www.ecancer.org for more. Prof Topp talks to ecancertv at ASCO 2014 about the results of a multicenter phase 2 study of the BiTE antibody blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia. The use of blinatumomab is an antibody ... View Video
Improved Survival In Patients With First Relapsed Or ...
Improved Survival in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML) Treated With Vosaroxin Plus Cytarabine Versus Placebo Plus Cytarabine: ... Visit Document
International Randomized Phase III Study Of Elacytarabine ...
International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia ... Retrieve Full Source
Phase I Study Using T Cells Expressing A CD123-specific ...
Phase I study using T cells expressing a CD123-specific chimeric antigen receptor and truncated EGFR for patients with relapsed or refractory acute myeloid leukemia ... Read Document
Prolonged Survival Of A Refractory Acute Myeloid Leukemia ...
CaseReport Prolonged Survival of a Refractory Acute Myeloid Leukemia Patient after a Third Hematopoietic Stem Cell Transplantation with Umbilical Cord Blood following a Second Relapse ... Retrieve Full Source
Targeting RUNX1-Mutated Refractory AML
Acute myeloid leukemia (AML) that harbors a RUNX1 mutation, but is cytogenically normal, has a poor diagnosis because it is often refractory to chemotherapy. Acute myeloid leukemia (AML) that harbors a RUNX1 mutation, but is cytogenically normal, has a ... Fetch Document
Use Of Gemtuzumab Ozogamicin In The Treatment Of Pediatric ...
38 Volume 25 • 1 • March 2008 Use of gemtuzumab ozogamicin in the treatment of pediatric relapsed/refractory Acute Myeloid Leukemia syndrome (MDS) transformed to AML, one patient ... Access Full Source
Acute myeloid leukemia - Wikipedia, The Free Encyclopedia
Acute myeloid leukemia with recurrent genetic abnormalities: Refractory anemia; Refractory anemia with excess of blasts; Chromosome 5q deletion syndrome; Sideroblastic anemia; Paroxysmal nocturnal hemoglobinuria; Refractory cytopenia with multilineage dysplasia; ... Read Article
Clofarabine Combinations As acute myeloid leukemia Salvage ...
Clofarabine Combinations as Acute Myeloid Leukemia Salvage Therapy Stefan Faderl, MD 1 Alessandra Ferrajoli, MD 1 William Wierda, MD, PhD 1 Xuelin Huang, PhD 2 Estey E. Treatment of relapsed and refractory acute mye-loid leukemia. Leukemia. 2000;14:476-479. 2. ... Read Full Source
Early Versus Late Preemptive Allogeneic Hematopoietic Cell ...
Early versus Late Preemptive Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory Acute Myeloid Leukemia George L. Chen1, Hong Liu1, Yali Zhang1, Julie Thomas1, Maureen Ross1, Eunice S. Wang2, ... Access This Document
ERYTECH Reports Financial Highlights For Q3 2015
LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, reports cash balance and revenues for the third quarter of 2015. ERYTECH ended the third quarter of 2015 with a total net cash position ... Read News
Fludarabine And Cytarabine In Patients With acute myeloid ...
And cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy Dhaval R. Mehta, Kenneth A. Foon, Robert L. Redner, Anastasios Raptis, Mounzer Agha, Jing-Zhou Hou, Shrina ... Doc Viewer
Improved Survival in Patients Age ≥60 Years With First Relapse/Refractory Acute Myeloid Leukemia Treated With Vosaroxin Plus Cytarabine vs Placebo Plus Cytarabine: Results From the Phase 3 VALOR Study ... Access This Document
Clozapine Use In Refractory Schizophrenia Comorbid With Acute ...
Case Reports Clozapine Use in Refractory Schizophrenia Comorbid With Acute Myeloid Leukemia Ting-She Chang, M.D., Chia-Kuang Tsai, M.D., Chih-Sung Liang, M.D. ... Fetch Content
Agios (AGIO) Reports Wider-than-Expected Loss In Q3
Agios Reports a loss of $1.07 in the third quarter of 2015. ... Read News
Facts About FCE (Fludarabine, Cytarabine, Etoposide) In Acute ...
Facts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia Bruno C. Medeiros Stanford University School of Medicine, Stanford, Calif. , USA with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induc- ... Fetch Full Source
Cellular Immunotherapy For refractory Hematological Malignancies
Cellular immunotherapy for refractory hematological malignancies John L Reagan1*, Loren D Fast1, Abstract Background: Acute myeloid leukemia (AML) and other aggressive refractory hematological malignancies unresponsive to upfront therapy remain difficult conditions to treat. ... Fetch Full Source
Celgene Reports Third Quarter 2015 Operating And Financial Results
Celgene Corporation reported net product sales of $2,313 million for the third quarter of 2015, an 18 percent increase from the same period in 2014. The negative net impact of currency on net product sales was 2 percent. ... Read News
G‐CSF Priming, Clofarabine, And High Dose Cytarabine (GCLAC ...
G-CSF Priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced ... Doc Viewer
Vosaroxin In acute myeloid Leukaemia - The Lancet
Combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia. Haematologica 2015; 100: 231–37. 5 Faderl S, Wetzler M, Rizzieri D, et al. Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or ... Doc Viewer
No comments:
Post a Comment